Look under the hood of sizzling headline inflation, and you’ll see it starting to cool.
The repercussions of US midterm elections will be felt over the coming months and years, not days. The key is how the results are transmitted to the economy, chiefly through monetary and fiscal policy.
With many aspects of the US economy in decent shape, we believe spread widening in a recession is likely to be limited. Still, investors no longer need to overreach on risk.
Global stock markets ended a holiday-shortened week — and a tumultuous year — on an upbeat note. The rally was attributed to hopes for a synchronous global recovery in 2021.
U.S. stocks were mixed during a holiday-shortened week; the Dow and NASDAQ posted modest gains; the S&P 500 posted a slight loss. Markets in Asia and Europe also were mixed.
Stocks advanced across the globe as distribution of the coronavirus vaccine gained momentum. U.S. market gains were tempered by uncertain prospects for a new coronavirus relief package.
Special needs planning is an emerging issue expected to become critical in the future; today, plan advisors have an opportunity to take the lead in addressing this concern with their clients.
Enjoy today’s cyclical bounce, prepare for tomorrow’s structural risk.
U.S. stocks broadly retreated and volatility advanced as investors grew skeptical about prospects for another coronavirus relief bill before year-end. Small caps, as measured by the Russell 2000 index, posted gains. Overseas bourses were mixed.
Voya’s Equity Machine Intelligence team aims to take emotion out of the investment process to deliver alpha that is uncorrelated to more traditional equity strategies.
Separating signal from noise with natural language processing techniques.
Despite the recent coronavirus surge and probable upcoming socially isolating, winter hunkering required, we think stocks can continue to hold their own against bonds.
Global stock markets posted another week of solid gains, and volatility eased as investor optimism rose. Sentiment got a lift from renewed hopes for a coronavirus aid package, and from the UK’s authorization to distribute the Pfizer-BioNTech coronavirus vaccine.